April 24, 2014
1 min read

Device for photorefractive intrastromal cross-linking approved in Canada

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The KXL II system, used to perform photorefractive intrastromal cross-linking, received regulatory approval in Canada, according to a press release from Avedro.

The cross-linking procedure, called PiXL, has the potential to deliver nonsurgical correction of myopia as well as improve cataract surgery outcomes, according to the release.

The device is designed to deliver specific light patterns to the cornea based on a patient’s topographic data.

The KXL II device previously received the CE mark in the European Union. Avedro products are not yet available for sale in the U.S., according to the release.